PM-10450

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePM-10450
Drug Alias NameZalypsisPM-10450PM-00104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-binding proteins modulatorsCell cycle proteins inhibitorsTranscription factors inhibitors
TargetsDNA-binding proteinsTranscription factorsCell cycle proteins
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharma Mar Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharma Mar Sa
Active IndicationsN/A
Inactive IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A